Men's telehealth brand BraveRX expands ED treatment line with Surge Max, a fast-dissolving tablet designed for faster onset than traditional swallowed pills.
-- BraveRX, a men’s pharmaceutical health brand, announced the Summer 2026 launch of Surge Max, an oral-dissolving mint tablet developed for the treatment of erectile dysfunction. Unlike conventional ED medications that must be swallowed and processed through the digestive system, Surge Max is designed to dissolve under the tongue.
This new tablet design allows the active ingredient, apomorphine, to be absorbed sublingually. In doing so, this is shown to be a much faster route that can elicit a reaction in a shorter amount of time than traditional ED pills. Surge Max is current available by prescription only and can be obtained following an online consultation with a licensed healthcare provider. It is compounded by a licensed pharmacy and ships to men in 49 states (all except North Dakota).
The launch expands BraveRX’s mission of making men’s health treatment discreet, accessible, and stigma-free. It is the latest in the brand’s product line that also includes a host of personalized treatment options to ensure that men find the medication they need for their individual bodies.
More information on Surge Max and BraveRX can be found on the website here: BraveRX.com.
About BraveRX
BraveRX is a telehealth brand that’s built around men’s health and breaking down the societal barriers that prevent many men from getting the help they need. Built around real science with real results, the company provides a host of professional treatment options for ED. 24/7 medical support and care are provided to all clients, and BraveRX uses real, licensed medical providers to conduct consultations, ensuring that the right treatment is prescribed to the right people.
Contact Info:
Name: BraveRX Media Relations
Email: Send Email
Organization: BraveRX
Address: 66 W Flagler Street, Suite 900, PMB 10902, Miami, FL 33130
Phone: 1 (833) 659-4576
Website: https://braverx.com/
Release ID: 89198118
In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.
